Press "Enter" to skip to content

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session

Gainers

  • Freight Technologies, Inc. FRGT shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.
  • Opiant Pharmaceuticals, Inc. OPNT shares jumped 114.9% to $20.20. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus contingent value rights (CVRs) of up to $8.00 per share.
  • ToughBuilt Industries, Inc. TBLT shares climbed 28.6% to $2.83 after the company reported better-than-expected Q3 EPS results.
  • Cosmos Holdings Inc. COSM rose 27.7% to $0.1569 after gaining 7% on Friday.
  • Yiren Digital Ltd. YRD jumped 27.7% to $1.29.
  • Exela Technologies, Inc. XELA gained 25.8% to $0.35.
  • Ardelyx, Inc. ARDX surged 25.6% to $1.5700. The FDA published briefing documents on Ardelyx’s kidney disease treatment.
  • Ensysce Biosciences, Inc. ENSC jumped 23% to $2.3700 after the company announced it received written guidance from the FDA that an acute pain indication may be appropriate for its lead Trypsin Activated Abuse Protection product, PF614.
  • CIRCOR International, Inc. CIR surged 20.6% to $26.15 following better-than-expected quarterly results.
  • HireRight Holdings Corporation HRT gained 19.1% to $9.18. HireRight’s board authorized a $100 million share repurchase program.
  • PDS Biotechnology Corporation PDSB jumped 18.2% to $6.62 after the company announced 100% clinical response in cervical cancer patients in preliminary data from the IMMUNOCERV Phase 2 clinical trial. The company also reported better-than-expected Q3 EPS results.
  • Daseke, Inc. DSKE gained 15.7% to $6.91. Daseke said that the company has entered into an agreement with its Founder, Mr. Don R. Daseke, and his affiliates, to repurchase their total holdings in the company at a purchase price of $6 per share.
  • HUTCHMED (China) Limited HCM rose 15.3% to $11.41 after the company reported positive topline result in Fruquintinib Phase III FRUTIGA study in second-line gastric cancer in China.
  • Armata Pharmaceuticals, Inc. ARMP jumped 14.6% to $3.29. Armata Pharmaceuticals recently reported a Q3 loss of $0.24 per share.
  • MINISO Group Holding Limited MNSO gained 14.5% to $8.10 after the company reported better-than-expected Q1 financial results.
  • Helius Medical Technologies, Inc. HSDT gained 14% to $0.2975 following strong quarterly results.
  • Agenus Inc. AGEN rose 13.8% to $2.8550. Agenus recently posted a Q3 loss of $0.19 per share.
  • HUTCHMED (China) Limited HCM surged 13.1% to $11.20 after the company reported initial results from FRUTIGA. The company said the trial met one of the primary endpoints of statistically significant improvement in progression-free survival.
  • Xinyuan Real Estate Co., Ltd. XIN surged 12.6% to $0.5181.
  • Babcock & Wilcox Enterprises, Inc. BW gained 10.4% to $5.38. Babcock & Wilcox Construction Co. LLC was awarded $42 million in large North American upgrade projects.
  • Secoo Holding Limited SECO gained 10.3% to $0.32.
  • TAL Education Group TAL gained 10.1% to $5.24.
  • Kidpik Corp. PIK rose 10.1% to $0.9798. KIDPIK is expected to release Q3 results on November 15, 2022.
  • monday.com Ltd. MNDY surged 9.2% to $103.94 after the company reported better-than-expected Q3 financial results.
  • Cabaletta Bio, Inc. CABA gained 8.8% to $2.59. Cabaletta Bio recently posted a Q3 loss of $0.39 per share.

Lufax Holding Ltd LU jumped 6.8% to $1.9550.

 



Losers

  • Satsuma Pharmaceuticals, Inc. STSA shares dipped 83.3% to $0.6781 after the company reported topline results from the STS101 SUMMIT Phase 3 efficacy trial in migraine patients.
  • SELLAS Life Sciences Group, Inc. SLS dipped 39.8% to $2.74 after the company reported Q3 earnings results and provided a business update.
  • POINT Biopharma Global Inc. PNT dropped 33% to $6.12. Lantheus and POINT Biopharma announced collaboration and exclusive license agreements for commercialization of PNT2002 & PNT2003.
  • Nuwellis, Inc. NUWE fell 31.7% to $0.1366. Nuwellis recently reported worse-than-expected Q3 EPS and sales results.
  • MorphoSys AG MOR shares fell 28.8% to $3.91. MorphoSys’ licensing partner Roche issued an update on Phase 3 GRADUATE program for Gantenerumab in early Alzheimer’s disease.
  • Stoke Therapeutics, Inc. STOK dipped 26% to $9.24 after the company reported a wider Q3 loss.
  • Actelis Networks, Inc. ASNS dropped 21.5% to $0.62. Actelis Networks posted a Q3 loss of $0.13 per share.
  • Tremor International Ltd TRMR fell 21.2% to $6.95 after gaining over 5% on Friday.
  • Infinity Pharmaceuticals, Inc. INFI dipped 21% to $0.9401. Infinity Pharmaceuticals posted a Q3 loss of $0.12 per share and issued an update from MARIO-3 study.
  • 908 Devices Inc. MASS declined 19.2% to $12.93 as the company lowered its FY22 revenue forecast.
  • Oatly Group AB OTLY fell 18.2% to $2.0050 after the company reported worse-than-expected Q3 EPS and sales results.
  • Fast Radius, Inc. FSRD shares fell 17.2% to $0.2015 after dropping around 7% on Friday.
  • Lumos Pharma, Inc. LUMO declined 16.5% to $7.44. Lumos Pharma posted a Q3 loss of $0.86 per share and disclosed interim results from two Phase 2 trials evaluating oral LUM-201 for moderate pediatric growth hormone deficiency.
  • TOMI Environmental Solutions, Inc. TOMZ dropped 16.4% to $0.6001. TOMI Environmental Solutions recently posted a Q3 loss of $0.03 per share.
  • Altus Power, Inc. AMPS dropped 15.2% to $7.24 following Q3 results.
  • Minerva Surgical, Inc. UTRS declined 15.4% to $0.2404.
  • CareMax, Inc. CMAX dipped 14.8% to $4.64. CareMax recently posted a Q3 loss of $0.25 per share.
  • Performance Shipping Inc. PSHG fell 14.4% to $0.2695. Performance Shipping posted Q3 EPS of $0.10.
  • Ascendis Pharma A/S ASND dipped 13.3% to $114.48. Ascendis Pharma announced positive topline results from the ACcomplisH Phase 2 trial of once-weekly TransCon CNP compared to a placebo in children with achondroplasia aged 2 to 10 years old.
  • Algonquin Power & Utilities Corp. AQN fell 12% to $8.18. Algonquin Power & Utilities Corp reported worse-than-expected Q3 EPS. Several analysts downgraded the stock today.
  • Transphorm, Inc. TGAN fell 11.7% to $6.22.
  • 5E Advanced Materials Inc. FEAM dropped 9.9% to $11.32. 5E Advanced Materials, on Friday, reported Q1 results.
  • CS Disco, Inc. LAW fell 9.6% to $9.35.
  • Kura Sushi USA, Inc. KRUS fell 9.4% to $59.64. Kura Sushi USA recently reported Q4 financial results.
  • 8×8, Inc. EGHT fell 9.4% to $4.3050.
  • Qurate Retail, Inc. QRTEA dropped 9.1% to $1.7450.
  • Bed Bath & Beyond Inc. BBBY fell 8.9% to $3.5977. Bed Bath & Beyond reported additional privately negotiated senior notes exchanges and concurrent private placement of common stock with several institutional holders.

This post was originally published on this site

Be First to Comment

Leave a Reply

Your email address will not be published.